0215915850
0215915880
0215915890
ICNA0215915850EA
75
EUR
InStock
ICNA0215915850
ICNA0215915880
ICNA0215915890
Ketoconazole ≥98%, poudre blanche
Ketoconazole
Ketoconazole is an antifungal agent; Cytochrome P450 inhibitor and demonstrates anti-psoriatic activity. A liver cytochrome responsible for the metabolism of many drug substrates in humans.
Ketoconazole is a broad spectrum antifungal agent used to treat candidiasis, chronic mucocutaneous candidiasis, oral thrush, candiduria, blastomycosis, coccidioidomycosis, histoplasmosis, chromomycosis, and paracoccidioidomycosis. It is a CYP3A4 inhibitor. It is used to identify p-glycoprotein/CYP3A-limited bioavailability in the monkey model, to study interleukin 1 mediated antitumor effects, and drug interactions in vivo.
Ketoconazole as an Antifungal agent, interacts with 14-α demethylase, a cytochrome P-450 enzyme that is necessary for the conversion of lanosterol to ergosterol. This interaction inhibits ergosterol synthesis and results in increased fungal cellular permeability. Other possible mechanisms of action are the inhibition of endogenous respiration, interaction with membrane phospholipids, inhibition of yeast transformation to mycelial forms, inhibition of purine uptake, and impairment of triglyceride and/or phospholipid biosynthesis. Ketoconazole inhibits the synthesis of thromboxane and sterols such as aldosterone, cortisol, and testosterone .
Soluble in DMSO or chloroform.